Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients

Хирургическая или транскатетерная замена аортального клапана у пациентов промежуточного хирургического риска
Thomas G. Gleason, G. Michael Deeb, Stephan Windecker, Neal S. Kleiman, A. Pieter Kappetein, Patrick W.J.C. Serruys, Jeffrey J. Popma, Nicolas M. Van Mieghem, David H Adams, Michael J. Reardon, Eberhard Grube, Nicolò Piazza, Stanley J. Chetcuti, Steven Joseph Yakubov, John V. Conte, Hemal Gada, Mathew Russell Williams, Raj R. Makkar, Peter Skov Olsen, Rüdiger Lange, Lars Søndergaard, Mubashir A. Mumtaz, Brijeshwar Singh Maini, John C. Heiser, William M. Merhi, Jae K. Oh, Joon S. Lee, Eric Vang, Hang Nga Nguyen, Yanping Chang, Andrew S. Mugglin
2017-03-17

Bayesian noninferiority analysisintermediate surgical risksevere aortic stenosissurgical aortic-valve replacementtranscatheter aortic-valve replacement
BACKGROUND: Although transcatheter aortic-valve replacement (TAVR) is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. METHODS: We evaluated the clinical outcomes in intermediate-risk patients with severe, symptomatic aortic stenosis in a randomized trial comparing TAVR (performed with the use of a self-expanding prosthesis) with surgical aortic-valve replacement. The primary end point was a composite of death from any cause or disabling stroke at 24 months in patients undergoing attempted aortic-valve replacement. We used Bayesian analytical methods (with a margin of 0.07) to evaluate the noninferiority of TAVR as compared with surgical valve replacement. RESULTS: A total of 1746 patients underwent randomization at 87 centers. Of these patients, 1660 underwent an attempted TAVR or surgical procedure. The mean (±SD) age of the patients was 79.8±6.2 years, and all were at intermediate risk for surgery (Society of Thoracic Surgeons Predicted Risk of Mortality, 4.5±1.6%). At 24 months, the estimated incidence of the primary end point was 12.6% in the TAVR group and 14.0% in the surgery group (95% credible interval [Bayesian analysis] for difference, -5.2 to 2.3%; posterior probability of noninferiority, >0.999). Surgery was associated with higher rates of acute kidney injury, atrial fibrillation, and transfusion requirements, whereas TAVR had higher rates of residual aortic regurgitation and need for pacemaker implantation. TAVR resulted in lower mean gradients and larger aortic-valve areas than surgery. Structural valve deterioration at 24 months did not occur in either group. CONCLUSIONS: TAVR was a noninferior alternative to surgery in patients with severe aortic stenosis at intermediate surgical risk, with a different pattern of adverse events associated with each procedure. (Funded by Medtronic; SURTAVI ClinicalTrials.gov number, NCT01586910 .).
1
In 1,660 intermediate-risk patients with severe symptomatic aortic stenosis, self-expanding TAVR was noninferior to surgical replacement for death or disabling stroke at 24 months.
2
No structural valve deterioration occurred in either treatment group during 24 months of follow-up.
3
Surgery caused more acute kidney injury, atrial fibrillation, and transfusion requirements, whereas TAVR caused more residual aortic regurgitation and pacemaker implantation.
4
TAVR produced lower mean transvalvular gradients and larger aortic-valve areas than surgery.
5
The 24-month primary-endpoint incidence was 12.6% after TAVR versus 14.0% after surgery, with a posterior probability of noninferiority greater than 0.999.

Severe, symptomatic aortic stenosis in intermediate-surgical-risk patients undergoing aortic-valve replacement

Comparative 24-month clinical outcomes and adverse-event profiles of transcatheter versus surgical aortic-valve replacement

Publication Details
Publication Date
2017-03-17
Journal
Publisher
ISSN
Cited by
3082
Access Type
Author Information
Authors
Thomas G. Gleason
G. Michael Deeb
Stephan Windecker
Neal S. Kleiman
A. Pieter Kappetein
Patrick W.J.C. Serruys
Jeffrey J. Popma
Nicolas M. Van Mieghem
David H Adams
Michael J. Reardon
Eberhard Grube
Nicolò Piazza
Stanley J. Chetcuti
Steven Joseph Yakubov
John V. Conte
Hemal Gada
Mathew Russell Williams
Raj R. Makkar
Peter Skov Olsen
Rüdiger Lange
Lars Søndergaard
Mubashir A. Mumtaz
Brijeshwar Singh Maini
John C. Heiser
William M. Merhi
Jae K. Oh
Joon S. Lee
Eric Vang
Hang Nga Nguyen
Yanping Chang
Andrew S. Mugglin
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%